Raw-materials supplier Granules India has ambitions to become a vertically-integrated oncology player as it exits joint ventures in the ibuprofen manufacturing and contract research and manufacturing services arenas.
Describing the group’s push into cancer treatments as “a long-haul process,” chairman and managing director Krishna Prasad Chigurupati said the firm had begun filing drug master files for oncology active pharmaceutical ingredients